Denis Chem Lab Limited has announced that its board of directors will meet on Saturday, May 30, 2026. The primary agenda for the meeting includes the consideration and approval of the standalone audited financial results for the financial year 2025-26, which ended on March 31, 2026.

Agenda for the Meeting

The board will deliberate on several key matters during the session. The first item on the agenda is the review and adoption of the audited financial statements for the full fiscal year. Following this, the directors will discuss the possibility of recommending a final dividend on equity shares for the financial year 2025-26. Any other business that may come before the board will also be addressed.

Trading Window Closure

In compliance with the Company’s Code of Conduct for the prevention of Insider Trading and the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for designated persons remains closed. This restriction will continue until 48 hours after the declaration of the audited financial results for the quarter and year ended March 31, 2026.

The company had previously intimated the exchange regarding this closure via a letter dated March 23, 2026.

Denis Chem Lab Limited, a manufacturer of parenteral products based in Ahmedabad, Gujarat, has informed BSE Limited of the resignation of its Secretarial Auditors, M/s. Nishant Pandya & Associates, Practising Company Secretaries. The resignation was communicated via a letter dated 6th May, 2026, and takes effect immediately, i.e., from Financial Year 2025-26 onwards. The disclosure was made in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Schedule III of the Listing Regulations and relevant SEBI Circulars.

Resignation Details

The outgoing Secretarial Auditors, M/s. Nishant Pandya & Associates, cited personal reasons for their resignation. The firm confirmed that there are no other material reasons for the cessation and raised no objection to the appointment of any other Secretarial Auditors by the company. The key disclosure particulars as submitted to the exchange, detailed in Annexure 1 of the filing, are presented below:

Regulatory Compliance

The intimation was submitted by Anal R. Desai, Company Secretary and Compliance Officer of Denis Chem Lab Limited, in accordance with the applicable provisions of the SEBI Listing Regulations. The resignation letter from M/s. Nishant Pandya & Associates was enclosed as an annexure to the filing. The firm, operating under Firm Registration Number S2019GJ700100, confirmed that it is no longer associated with the company in the capacity of Secretarial Auditors for Financial Year 2025-26.